Sipuleucel‐T associated inflammatory cardiomyopathy: a case report and observations from a large pharmacovigilance database

AIMS: The major cardiovascular (CV) adverse effects observed with sipuleucel‐T from large multi‐institutional clinical trials included thromboembolic events, myocardial infarction, and congestive heart failure in up to 0.3% of patients with CV risk factors. The incidence, outcomes, and mechanisms in...

Descripción completa

Detalles Bibliográficos
Autores principales: Moey, Melissa Y.Y., Jiwani, Rahim A., Takeda, Kotaro, Prenshaw, Karyn, Kreeger, R. Wayne, Inzerillo, John, Liles, Darla K., Marcu, C. Bogdan, Lebrun‐Vignes, Bénédicte, Morris, D. Lynn, Ardhanari, Sivakumar, Salem, Joe‐Elie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318408/
https://www.ncbi.nlm.nih.gov/pubmed/33938158
http://dx.doi.org/10.1002/ehf2.13400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318408/
https://www.ncbi.nlm.nih.gov/pubmed/33938158
http://dx.doi.org/10.1002/ehf2.13400

Ejemplares similares